A study was conducted to see whether patients with duodenal ulcers that failed to heal in response to H2 receptor antagonists had a higher incidence of recurrent ulceration after highly selective vagotomy than patients whose ulcers healed with these drugs. Between 1977 and, 157 patients had a highly selective vagotomy for uncomplicated duodenal ulcer; in 57 patients the ulcer had failed to heal despite treatment with H2 receptor antagonists (refractory group), 19 patients had developed recurrent ulceration while receiving maintenance treatment, 67 patients had remained healed while taking H2 receptor antagonists but suffered frequent relapses when treatment was stopped, and 14 patients had not been given these drugs before operation. The overali incidence of recurrent ulceration was 6% after two years and 11% after five years of foliow up. In the refractory group, however, the incidence of recurrent ulceration was 18% at two years and 34% after five years, whereas the incidence of recurrence was only 1-5% at two years and 3% after five years in patients whose ulcers had healed with H2 receptor antagonists. Resistance to H2 receptor antagonists was not related to preoperative basal or peak acid output but was related to cigarette smoking. Factors associated with recurrent ulceration after highly selective vagotomy were basal acid outputs before and after operation, cigarette smoking, and the surgeon who performed the operation.
Introduction
The H2 receptor antagonists cimetidine and ranitidine have revolutionised the management of duodenal ulceration. They are very effective in healing duodenal ulcers, endoscopic healing rates of over 80% readily being achieved after six weeks.' There is a subgroup of patients, however, whose ulcers fail to respond even to these potent drugs. By definition a duodenal ulcer that fails to heal after three months of treatment is termed "refractory."' Though such ulcers sometimes heal if treatment with H2 receptor antagonists is continued for longer, or in response to other drugs such as mucosal barrier agents,3 these patients represent a problem in management for gastroenterologists and are frequently referred for surgical treatment. Apart from refractory duodenal ulcers there are other categories of failure with H2 receptor antagonists. Some patients have ulcers that heal with full dosage of the drugs but recur during maintenance treatment, usually given as a single night time dose of 400 mg cimetidine or 150 mg ranitidine. Other patients remain healed during maintenance treatment but suffer frequent, rapid, and troublesome relapses when treatment is stopped. Because either the patient or the physician is unwilling to continue treatment for life, these patients with "relative" failure of H2 receptor antagonists may also be referred for surgery.
Highly selective vagotomy is the safest operation for duodenal ulceration4 and has the fewest side effects.5-8 Incidences of recurrent ulceration ranging from 2% to 30% have been reported five to eight years after highly selective vagotomy,69 but when the procedure has been carried out by experienced surgeons using standard techniques an incidence of recurrent ulceration of 5-10% after five years has often been achieved.56 1011 Many of these studies, however, were begun or even completed before H2 receptor antagonists became widely available and thus before failure of response to H2 receptor antagonists became the main criterion for selection of patients for operation.
The aim of this study was to determine the effectiveness of highly selective vagotomy for patients with duodenal ulceration who belonged to various categories of response to H2 receptor antagonists. In particular we wished to know whether ulcers that had failed to heal in response to these drugs would heal and remain healed after highly selective vagotomy. of the drug and subsequent maintenance treatment. They were referred for surgical treatment because of troublesome relapses of symptoms when treatment was stopped, and recurrence of the ulcer was confirmed endoscopically. As healing was not always checked by gastroscopy when patients were asymptomatic, possibly some both in this group and the group who relapsed during maintenance treatment had asymptomatic but unhealed ulcers at some stage in their treatment. They may therefore have been more "refractory" than their classification suggests. No H2 receptor antagonists-Fourteen patients were operated on without receiving treatment with H2 receptor antagonists. Operations were elective but usually for an acute complication of duodenal ulcer disease such as haematemesis or melaena, surgical treatment being preferred to reduce the likelihood of further complications.
Of the 157 patients, 57 had ulcers refractory to H2 receptor antagonists, 19 had relapsed during maintenance treatment, 67 patients had healed with H2 receptor antagonists but were operated on for frequent, troublesome relapses, and 14 patients had never received H2 receptor antagonists. The groups were similar with respect to age, sex, and body weight, with the exception of the fourth group, which consisted entirely of men (table I) .
Tests ofgastric secretion-Each patient had a combined insulin-pentagastrin test2 13 before and one week after operation. The Figure 2 gives the individual results for the four surgeons who performed most of the operations together with the results of 14 other surgeons, considered as a group, each of whom had performed only a few operations. There was considerable intersurgeon variation in the incidence of recurrent ulceration, the difference being significant between surgeons A and B (p<005). Recurrences tended to occur among patients in the refractory group, but even in these patients some surgeons achieved much better results than others. For example, after five years of follow up three of 13 patients in the refractory group operated on by surgeon A had suffered a recurrence compared with three of five patients operated on by surgeon B.
Cigarette smoking- Table IV shows the patients' smoking habits. Patients in the refractory group were the heaviest smokers, and patients who relapsed during maintenance treatment smoked more than those who remained healed with H2 receptor antagonists. The difference between the refractory and healed groups was significant (p<005). Patients who suffered recurrent ulceration after vagotomy smoked almost twice as many cigarettes daily as patients who did not have a recurrence (p<005).
Discussion
In the post-cimetidine era the overall incidence of symptomatic recurrent ulceration after elective highly selective vagotomy for duodenal ulcer in this department was 6% at two years and 11% at five years (life table analysis). These incidences were higher than reported before the introduction of cimetidine. 11-13 19 Such historical comparisons are open to criticism because of the presence of uncontrolled variables such as changes in surgical staff and possibly changing patterns of referral. Nevertheless, we believe that since the introduction of H2 receptor antagonists a less favourable group of patients with a more intractable ulcer diathesis is being referred for surgical treatment. The most striking feature of our results is the very high incidence of recurrent ulceration (34%) at five years among patients whose ulcers had failed to heal despite three months of H2 receptor antagonist in full dosage. This incidence was significantly higher than among patients whose ulcers had healed the accuracy of the results, as not all patients were treated. We find that patients with recurrent dyspepsia attend the clinic even if they have defaulted previously, so the incidence of recurrent ulceration may be less than calculated by the life table method. Nevertheless, even if all the patients in the refractory group who were not traced remained asymptomatic the incidence of recurrent ulceration in the refractory group would still be significantly higher than in the group who healed with H2 receptor antagonists.
That patients whose ulcers fail to heal in response to H2 receptor antagonists might also have a high incidence of recurrent ulceration after highly selective vagotomy has been considered before. Weaver and Temple, for example, found that highly selective vagotomy was effective treatment in patients who had been classed as failures with H2 receptor antagonists, only one case of recurrent ulceration being found among 64 patients followed up for one to four years after operation.20 By contrast, Hansen and Knigge reported that no fewer than 17 of 45 patients who had been classed as cimetidine failures suffered recurrent ulceration between 20 and 67 months after highly selective vagotomy.2" Their study has been criticised, however, firstly, because a large number of surgeons were performing small numbers of highly selective vagotomies over a long period and, secondly, because no intraoperative or postoperative quality control was used, such as the Grassi22 or insulin test.23 In both studies patients had been referred because of "failure of H2 receptor antagonists" but in neither study were they subdivided according to the precise nature of their preoperative responses to these drugs. In our study we found a precise definition of the preoperative response to H2 receptor antagonists to be essential.
To try to define possible causes of failure of response, both to H2 receptor antagonists and to surgical treatment, we examined such factors as the preoperative and postoperative basal and peak acid outputs, the results of the postoperative insulin test, the number of cigarettes smoked, and the surgeon who performed the operation. No correlation was found between the response to H2 receptor antagonists and the preoperative and postoperative acid outputs. Basal acid output, however, was higher both before and after operation in patients who suffered recurrent ulceration after highly selective vagotomy than in patients who did not have recurrences; this has been noted before. 24 When the peak acid responses to pentagastrin in patients with recurrent ulceration were compared with those in patients without recurrence no significant differences were found either before or after operation.
The failure of the postoperative insulin test, as judged by several criteria, to predict recurrent ulceration after highly selective vagotomy was surprising, because we had previously found a correlation between Hollander positive insulin test results one week after operation and subsequent recurrent ulceration.9 A possible explanation may be the small number of patients (14) who suffered recurrent ulceration in this series. An alternative explanation may be that the insulin test seeks to elicit an acid response and the magnitude of that response one week after operation may not be the principal determinant of recurrent ulceration in these patients with refractory ulceration.
In contrast with the weak influence of acid output on subsequent recurrent ulceration the effects of cigarette smoking, both on resistance to H2 receptor antagonists and on recurrence after highly selective vagotomy, were more convincing. Patients with refractory ulcers smoked significantly more cigarettes daily than patients whose ulcers remained healed with these drugs, and patients who suffered recurrent ulceration after highly selective vagotomy smoked almost twice as many cigarettes as patients who did not have a recurrence. All the patients with refractory ulceration who suffered a recurrence smoked. Though there is no simple relation between smoking and acid output,25127 it has been shown that duodenal ulcers heal more slowly in smokers than non-smokers and that ulcer relapse rates after treatment is stopped are higher in smokers than non-smokers.28 Resistance 
Scale of the problem
The number of drug smugglers entering the United Kingdom has increased considerably over the past few years. The United Kingdom and Europe are now considered to be a growing market, as the American market is saturated with drugs and wholesale prices there are falling. Rates of detection have risen not only because of the growing numbers of smugglers but also because of more intelligence and better understanding of the habits of the organisers of the drug trade and methods used for concealing drugs. Sophisticated technology such as sniffer devices and kits of highly sensitive tests for confirming the presence of specific drugs in body fluids or on clothing plays a part in the detection of these crimes.
We analysed data supplied by HM Customs and Excise for September 1986. Of the 56 drug seizures at ports in the United Kingdom, 38 were of heroin (total 13-84 kg), 10 of cannabis (total 1288 kg), and eight of cocaine (total 4-15 kg). In 28 cases the drugs were concealed by swallowing or in the vagina or rectum. Thirty nine of the seizures were made at London Heathrow Airport and 11 at London Gatwick Airport. Other ports used during the month studied were Dover, Ramsgate, Folkestone, Plymouth, and the Scilly Isles. In other months Immingham, Liverpool, Bristol, Sheerness, and Glasgow have been used as ports of entry.
Interpol intelligence suggests that trafficking of cocaine is increasing considerably. In the first nine months of 1986 there were 47 seizures at European airports, amounting to 43 kg cocaine. Most of the 66 Colombians arrested after swallowing drugs were men aged 25-35. They were usually on their first trip to Europe, wearing a new suit and carrying a new Colombian or a forged Spanish or Portuguese passport. The maximum number of packets swallowed was 110; the total weight of cocaine ranged from 500 to 1290g.
For every smuggler caught unknown numbers evade detection. In a recent exercise customs officers in Madrid made 800 passengers who had aroused their suspicion pass through an x ray machine. Radiological signs compatible with the presence of packets of cocaine in the gastrointestinal tract were seen in 160. We believe that few of these stuffers and swallowers appreciate the risk they take with their lives. Many are from poor backgrounds and are probably regarded by the organisers as expendable.
Interpol intelligence suggests that Colombian traffickers tend to concentrate on smaller European air and sea ports. At present 90% of all seizures of drugs in the United Kingdom take place at the two London airports. We suspect that these figures will change appreciably over the next year or so. Certainly, customs officers at all points of entry to the United Kingdom are now more vigilant. Thus more suspects will probably be taken to more hospitals with suspected perforation, with obstruction, or simply for radiological examination.
Ashford Hospital is close to London Heathrow Airport. We examine about six suspects a month radiologically to try to identify whether they have concealed drugs in their body. The customs officer in charge of the case obtains written permission from the subject before radiographs are taken.
